Ending cervical

cancer through

prevention,

research,

and access to care

Our Impact

In collaboration with local Ministries of Health

Women screened for cervical cancer

Women treated for cervical cancer

Health professional trained

Publications

Countries Served

We are globally recognized as a leader in the prevention of cervical cancer.

 

We provide clinical training, research, and public policy guidance in cervical cancer screening and treatment, particularly for women in limited-resource settings.

Where We’ve Worked

Caribbean Focus

Impact Stories

Click to watch their stories of hope. strength. resilience.

“I’m Rosa, 55 years old, a homemaker from Cantón Hoyos, El Salvador. When my doctor diagnosed me with cancer, I had known something was wrong for a long time — but traveling far for treatment felt impossible. Basic Health International gave me the helping hand I never imagined finding. Today I am finally receiving treatment, and I am determined to heal.”

Rosa

Ilobasco, El Salvador

“When they told me I had cancer, I felt I had no hope and no reason to live. I went through 27 radiation sessions, chemotherapy, and brachytherapy — but Basic Health International was with me at every step, helping with transportation and care. Today I tell other women: don’t give up and don’t lose faith, because just as I overcame it, you will too.”

Ana Gladis

Usulután, El Salvador

“I’m Santos Cristina, a single mother from Tecoluca, El Salvador. When I was diagnosed with cancer, I feared I would die and leave my children behind. Basic Health International guided me through every step and never let me feel alone. Today I’m working again, and I made sure my daughter got her HPV vaccine.”

Santos Cristina

Tecoluca, El Salvador

Live free of cervical cancer

Join Our Mailing List!

1. Scientific & Academic Research


We conduct rigorous scientific and academic research to test, validate, and refine novel cervical cancer prevention strategies. Our research focuses on identifying approaches that improve early detection and treatment while remaining feasible in real-world health systems.

This includes:

  • Evaluating high-performance HPV screening technologies
  • Studying self-collection and alternative screening models to reach under-screened populations
  • Generating evidence to inform national and global policy decisions

By partnering with academic institutions, ministries of health, and clinical researchers, we ensure that our findings contribute to the global evidence base and directly inform practice.

This will close in 0 seconds